AI-generated summary
The authors report a randomized, double-blind, placebo-controlled trial of laser acupuncture versus placebo laser for major depression in 47 adults in Sydney. At eight weeks, the active laser group showed greater improvement on the clinician-rated and primary depression scales, with higher response and remission rates than placebo. Self-reported scores did not differ significantly between groups.
- Participants
- 47
- Who or what was studied
- Adults aged 18-50 years with DSM-IV major depressive disorder, recruited in Sydney, Australia
- Limits stated in the abstract
- The abstract notes there was no follow-up for the placebo group at one and three months.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, Depression, Primary outcome. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.